Allegis Investment Advisors’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
$806K Sell
9,040
-15,595
-63% -$1.5M 0.25% 88
2017
Q4
$2.57M Buy
24,635
+1,057
+4% +$119K 0.76% 31
2017
Q3
$3.44M Sell
23,578
-462
-2% -$62.9K 0.81% 31
2017
Q2
$3.12M Buy
24,040
+2,772
+13% +$340K 0.79% 26
2017
Q1
$2.65M Buy
21,268
+8,844
+71% +$1.06M 0.7% 32
2016
Q4
$1.44M Buy
12,424
+2,486
+25% +$277K 0.45% 69
2016
Q3
$1.04M Buy
9,938
+4,415
+80% +$478K 0.4% 88
2016
Q2
$546K Buy
5,523
+613
+12% +$63.4K 0.27% 111
2016
Q1
$491K Buy
4,910
+1,798
+58% +$185K 0.28% 113
2015
Q4
$373K Buy
+3,112
New +$360K 0.21% 126

Other funds holding CELG

Allegis Investment Advisors's CELG Position: Q1 2018 in Review

Allegis Investment Advisors reduced its Celgene Corp (CELG) stake by 63% in Q1 2018, selling an estimated $1.5M and leaving 9,040 shares worth $806K. The position accounts for 0.25% of the portfolio, ranked #88.

Allegis Investment Advisors first reported a position in CELG in Q4 2015 and has held it in 10 quarters since. The position peaked at $3.44M in Q3 2017. 1,397 funds tracked by Wall St. Rank hold CELG as of Q1 2018.

  • Allegis Investment Advisors held 9,040 shares of Celgene Corp worth $806K as of Q1 2018.
  • Allegis Investment Advisors sold 15,595 Celgene Corp shares in Q1 2018, an estimated $1.5M.
  • Celgene Corp made up 0.25% of Allegis Investment Advisors's portfolio in Q1 2018, its #88 holding.
  • Allegis Investment Advisors first reported a position in Celgene Corp in Q4 2015 and has held it in 10 quarters since.
  • Allegis Investment Advisors's Celgene Corp position peaked at $3.44M in Q3 2017.
  • 1,397 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2018.

Based on Allegis Investment Advisors's 13F filing for Q1 2018, filed 24 Apr 2018.